BMRA logo

BIOMERICA INC

BMRANASDAQ
πŸ† #3742 by market capUS Equity
$1.60β–² $0.15 (+9.22%)
Live
1hβ€”
24hβ–² 9.2%
7dβ–² 9.2%
14dβ–Ό 3.6%
30dβ–Ό 9.9%
1yβ–Ό 48.6%
🏦Market Cap
$5M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-23.8%
Declining
πŸ“ŠGross Margin
4.3%
Thin
πŸ’΅FCF Margin
83.9%
Strong
βš–οΈP/S Ratio
1.2x
Cheap
Otter Score
64
Fair

Trading Snapshot

Day Range
$1.59 – $1.61
52-Week Range
$1.45 – $4.60
Volume
$2.84B
Avg Volume
$3.17B
Shares Outstanding
3.1M
Next Earnings
Oct 23, 2026

Fundamentals Snapshot

Annual Revenue
$4M
Last Q Revenue
$1M
P/E Ratio
β€”
P/S Ratio
1.2x
EPS (TTM)
$-1.59
Dividend Yield
β€”

Why Investors Own BMRA

  • βœ“High-growth profile β€” revenue up +49.5% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 29% gross margin and 21% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$4Mβ–² +52.7% YoY
Gross Margin (TTM)
28.6%β–² +3.2% YoY
Operating Income (TTM)
$611,106β–² +52.7% YoY
Free Cash Flow (TTM)
$910,249β–² +52.7% YoY

About BIOMERICA INC

A company profile for BIOMERICA INC isn’t available yet β€” check back soon.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
64/100

Analyst Ratings

β“˜
Consensus
Buy
7 analysts
Strong Buy3
Buy3
Hold1
Sell0
Strong Sell0
Ratings as of Jul 2022

Latest News & Updates